Gregory Albers, MD
Vascular Neurology · Stanford, CANPI 1205889698
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $382,870 of the $414,856 with a category attached, or 92.3%. 24 manufacturers reported payments, led by Genentech, Inc. at 39.3% of the total. Reporting peaked in 2019 at $121,281 and has fallen 59.2% since, to $49,526 in 2025. Among vascular neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $4998.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$163K
- Ischemaview, Inc.$160K
- F. Hoffmann-la Roche AG$20K
- Astrazeneca UK Limited$15K
- Portola Pharmaceuticals, LLC$8K
- Bayer$7K
- plus $42K from 18 others
Across 6 payments — averaging $1189.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$5K
- F. Hoffmann-la Roche AG$2K
What the payments were for
- Consulting fees$382,87092%
- Speaking & faculty fees$6,7672%
- Travel & lodging$23,1966%
- Food & beverage$2,0240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 17 | $163,135 |
| Ischemaview, Inc. | 4 | $160,000 |
| F. Hoffmann-la Roche AG | 9 | $19,604 |
| Astrazeneca UK Limited | 9 | $15,216 |
| Portola Pharmaceuticals, LLC | 10 | $7,508 |
| Bayer | 7 | $7,392 |
| Janssen Research & Development, LLC | 3 | $6,850 |
| Astrazeneca AB | 2 | $6,402 |
| Argenx US, Inc. | 1 | $5,175 |
| CSL Behring | 1 | $4,200 |
| AstraZeneca | 2 | $3,953 |
| Janssen Global Services, LLC | 1 | $3,750 |
| Biogen | 2 | $3,718 |
| Medtronic | 2 | $3,200 |
| Daiichi Sankyo Inc. | 1 | $2,060 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,800 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $131 |
| Genentech USA, Inc. | 1 | $131 |
| Ceribell, Inc. | 1 | $125 |
| Nestle Healthcare Nutrition Inc. | 1 | $125 |
| Boston Scientific | 2 | $114 |
| Apollo Endosurgery US Inc | 1 | $111 |
| Celltrion USA Inc. | 1 | $95 |
| American Regent | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TNKase$141,194
- Activase$139,885
- Cathflo Activase$137,987
- ANDEXXA$7,250
- BRILINTA$3,953
- XARELTO$2,800
- INJECTAFER$2,060
- POCKET EEG DEVICE$125
- VOWST$125
- OverStitch Endoscopic Suturing System$111
How this compares
$414,856 in reported general payments places this provider in the 95th percentile of 58 vascular neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in Stanford
- Chitra VenkatasubramanianStanford$260K
- Maarten LansbergStanford$86K
- Sarah LeeStanford$35K
- Nirali VoraStanford$5K
- Neeharika KrothapalliStanford$959
- Lironn KralerStanford$20
- Shuichi SuzukiArcadia$126K
- Royya ModirSan Diego$113K
- Muhammad TaqiPalm Springs$77K
- Ashish NandaFullerton$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.